CIK 0001598646
- Non-accelerated filer
- Smaller reporting company
Minerva Neurosciences, Inc.
Sign in to watch- Ticker
- NERV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 260784194
- Phone
- +1 617-600-7373
- Business address
- 1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-16 | Index Venture Associates III Ltd 10% owner | Sale | −44,836 | $6.37 | $286K | 4,474,361 |
| 2019-05-15 | Index Venture Associates III Ltd 10% owner | Sale | −53,418 | $6.64 | $354K | 4,519,197 |
| 2019-05-14 | Index Venture Associates III Ltd 10% owner | Sale | −36,574 | $7.05 | $258K | 4,572,615 |
| 2018-12-20 | DOYLE WILLIAM F Director | Purchase | +2,000 | $6.50 | $13K | 22,611 |
| 2018-12-17 | Race Geoff EVP, CFO & CBO | Sale | −5,999 | $7.46 | $45K | 198,370 |
| 2018-12-17 | Ahlholm Frederick W SVP, Chief Accounting Officer | Sale | −1,559 | $7.46 | $12K | 11,780 |
| 2018-12-17 | Luthringer Remy CEO | Sale | −2,604 | $7.46 | $19K | 32,702 |
| 2018-12-17 | Reilly Joseph H. SVP & Chief Operating Officer | Sale | −2,728 | $7.46 | $20K | 20,199 |
| 2018-12-14 | Race Geoff EVP, CFO & CBO | Option exercise | +12,500 | 204,369 | ||
| 2018-12-14 | Race Geoff EVP, CFO & CBO | Option exercise · Restricted Stock Unit | −12,500 | 25,000 | ||
| 2018-12-14 | Ahlholm Frederick W SVP, Chief Accounting Officer | Option exercise | +5,000 | 13,339 | ||
| 2018-12-14 | Ahlholm Frederick W SVP, Chief Accounting Officer | Option exercise · Restricted Stock Unit | −5,000 | 10,000 | ||
| 2018-12-14 | Luthringer Remy CEO | Option exercise | +18,750 | 35,306 | ||
| 2018-12-14 | Luthringer Remy CEO | Option exercise · Restricted Stock Unit | −18,750 | 37,500 | ||
| 2018-12-14 | Reilly Joseph H. SVP & Chief Operating Officer | Option exercise | +8,750 | 22,927 | ||
| 2018-12-14 | Reilly Joseph H. SVP & Chief Operating Officer | Option exercise · Restricted Stock Unit | −8,750 | 17,500 | ||
| 2018-12-12 | Russell Richard E. President | Sale | −3,117 | $7.96 | $25K | 36,883 |
| 2018-12-11 | Smith Devin Whittemore SVP and General Counsel | Grant or award · Employee Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2018-12-11 | Saoud Jay SVP and Head of R&D | Grant or award · Employee Stock Option (right to buy) | +96,000 | 96,000 | ||
| 2018-12-11 | Russell Richard E. President | Grant or award · Employee Stock Option (right to buy) | +260,000 | 260,000 |
Page 8 of 16 · 305 trades